Cartesian Therapeutics (RNAC) Receivables - Other (2020 - 2024)
Cartesian Therapeutics (RNAC) posted quarterly Receivables - Other of $980000.0 for Q3 2024, down 47.73% year-over-year from $1.9 million in Q4 2023, and down 71.77% quarter-over-quarter from $3.5 million in Q2 2024.
Cartesian Therapeutics (RNAC) Receivables - Other (2020 - 2024) Analysis & Trends
Cartesian Therapeutics (RNAC) has reported Receivables - Other for 5 consecutive years, with $980000.0 the latest figure, recorded in Q3 2024.
- In Q3 2024, Receivables - Other fell 47.73% year-over-year to $980000.0; the TTM figure through Sep 2024 stood at $980000.0 (down 47.73% YoY), while the FY2023 annual figure was $3.0 million, down 5.72% from the prior year.
- Receivables - Other declined to $980000.0 in Q3 2024 per RNAC's latest filing, from $3.5 million in the prior quarter.
- Across five years, Receivables - Other topped out at $3.5 million in Q2 2024 and bottomed at $100000.0 in Q3 2021.
- Historically, Receivables - Other has averaged $1.6 million across 5 years, with a median of $1.1 million in 2023.
- Annual changes were most pronounced in 2021 — Receivables - Other sank 80.0% — and 2024, when it soared 229.1%.
- Cartesian Therapeutics' Receivables - Other stood at $1.0 million in 2020, then sank by 90.0% to $100000.0 in 2021, then jumped by 3062.0% to $3.2 million in 2022, then slipped by 5.72% to $3.0 million in 2023, then slumped by 67.13% to $980000.0 in 2024.
- Business Quant data shows RNAC's Receivables - Other at $980000.0 in Q3 2024, $3.5 million in Q2 2024, and $2.4 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Cartesian Therapeutics | 265.54 Mn | 265.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 980,000.00 |
| Sep 30, 2024 | 980,000.00 |
| Jun 30, 2024 | 3.47 Mn |
| Jun 30, 2024 | 3.47 Mn |
| Mar 31, 2024 | 2.37 Mn |
| Mar 31, 2024 | 2.37 Mn |
| Dec 31, 2023 | 2.98 Mn |
| Dec 31, 2023 | 2.98 Mn |
| Sep 30, 2023 | 1.88 Mn |
| Sep 30, 2023 | 1.88 Mn |
| Jun 30, 2023 | 1.06 Mn |
| Jun 30, 2023 | 1.06 Mn |
| Mar 31, 2023 | 1.84 Mn |
| Mar 31, 2023 | 1.84 Mn |
| Dec 31, 2022 | 3.16 Mn |
| Dec 31, 2022 | 3.16 Mn |
| Sep 30, 2021 | 100,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 1.00 Mn |
| Jun 30, 2021 | 1.00 Mn |